Separately, TheStreet downgraded Mannatech from a “b” rating to a “c+” rating in a research note on Tuesday, June 7th.
Shares of Mannatech stock opened at $16.55 on Wednesday. The business has a 50-day moving average price of $27.74 and a two-hundred day moving average price of $33.30. The company has a market cap of $32.27 million, a P/E ratio of 4.43 and a beta of 1.14. Mannatech has a 1-year low of $16.50 and a 1-year high of $49.08.
In other Mannatech news, Director Kevin Andrew Robbins sold 1,100 shares of Mannatech stock in a transaction that occurred on Monday, March 28th. The shares were sold at an average price of $36.57, for a total transaction of $40,227.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 50.00% of the stock is owned by company insiders.
Several large investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its holdings in shares of Mannatech by 43.9% in the 4th quarter. JPMorgan Chase & Co. now owns 2,703 shares of the company’s stock worth $104,000 after purchasing an additional 824 shares during the period. Hillsdale Investment Management Inc. purchased a new position in Mannatech in the 1st quarter valued at approximately $31,000. Morgan Stanley purchased a new position in Mannatech in the 3rd quarter valued at approximately $41,000. Renaissance Technologies LLC grew its stake in Mannatech by 2.7% in the 4th quarter. Renaissance Technologies LLC now owns 61,299 shares of the company’s stock valued at $2,349,000 after buying an additional 1,600 shares in the last quarter. Finally, LSV Asset Management grew its stake in Mannatech by 1,090.3% in the 1st quarter. LSV Asset Management now owns 7,142 shares of the company’s stock valued at $261,000 after buying an additional 6,542 shares in the last quarter. 31.96% of the stock is currently owned by institutional investors.
About Mannatech (Get Rating)
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.
- Get a free copy of the StockNews.com research report on Mannatech (MTEX)
- This Still Isn’t A Buyable Bottom For Stocks
- ABM Industries, A Clean Play For Dirty Economic Times
- Should Silver Stocks Be A Part Of Your Portfolio?
- Don’t Get Too Bullish On Lennar Even Though It’s A Good Buy
- Dividend-Paying Midstream Oil Companies That Could Help You The Mitigate Market Volatility
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.